台灣竟有720萬人是肝癌高風險族群？以為不喝酒就沒事，大錯特錯！跟著肝膽權威一起「自我檢視」，斬斷肝病三部曲！｜專訪肝膽胰內科權威 高雄醫學大學校長 余明隆醫師

Many people believe that not drinking alcohol will prevent liver disease, but they overlook the fact that fatty liver has already become a key factor in the development of liver cancer! This episode of "Top 100 Doctors' Forum" features a special interview with Dr. Yu Ming-Lung, President of Kaohsiung Medical University and a leading authority in hepatobiliary and pancreatic medicine. From all-oral medications to "targeted immunotherapy" for combating mid-to-late stage liver cancer, understanding that seizing the golden treatment period can lead to successful reversal! Don't let your silent organs cry out; follow this authoritative doctor to cut through the three stages of liver disease! — 0:00 Interview with Dr. Yu Ming-Lung, Leading Authority in Hepatobiliary and Pancreatic Medicine 2:08 Five Types of Hepatitis A to E: Different Transmission Routes 3:23 Hepatitis B, C, and D: Not Transmitted Through Food; No Need to Panic About Sharing Food 3:59 Why is Hepatitis B So Prevalent in Taiwan? Main cause: Vertical transmission from mother to child 5:28 Comprehensive vaccination of newborns successfully blocks hepatitis B infection 6:30 Nine out of ten children infected in childhood become carriers; adults' immune systems mature and clear the virus on their own 7:42 Chronic hepatitis gradually leads to fibrosis; beware of the three stages of liver disease 8:47 Cirrhosis may lead to liver failure and even liver cancer 9:19 There are no pain receptors deep in the liver; abnormalities are often detected in the late stage 9:46 Hepatitis C rarely spreads vertically; the chance of transmission to children is low 10:21 Hepatitis D is a parasitic virus that needs to attach to hepatitis B to survive 11:05 Excessive intake of high-calorie foods may lead to fatty liver disease 12:16 In Europe and America, the number of patients requiring transplants due to fatty liver has exceeded that of viral liver cancer 12:52 Excessive alcohol consumption should be avoided; beware of alcoholic hepatitis 14:01 Fundamental differences between hepatitis B and hepatitis C: DNA and RNA are very different 14:35 Hepatitis B virus is deeply embedded in liver cells and is difficult to eradicate completely in life 15:25 Novel oral antiviral drug clears 98% of type C virus 15:56 Hepatitis C easily triggers immune response; beware of systemic complications 17:32 Early liver disease has no obvious symptoms; regular checkups detect lesions 18:32 What are liver markers (GOT, GPT)? 19:11 Traditional testing is too cumbersome; automated reflex testing system is introduced. 20:16 Cumbersome procedures reduce willingness to return for follow-up visits, leading to missed opportunities for early treatment. 21:26 Introduction of automated reflex testing system to identify hidden hepatitis C patients. 22:25 Implementing community screening through automated reflex testing system. 23:32 Combining oral medication with hepatitis C treatment can clear it in eight to twelve weeks. 24:08 The golden cross-section of hepatitis B treatment: grasping the critical period of treatment. 26:51 Regularly tracking changes in liver indexes to seize the best treatment opportunity. 28:00 Interferon and oral medications effectively inhibit hepatitis B virus. 30:00 Functional cure is difficult and requires long-term medication for control. 30:57 Blocking mother-to-child vertical transmission: the three-step approach to preventing hepatitis B infection. 32:35 Medical teams take the initiative to go to the source of infection to identify potential patients. 34:52 Don't panic if you find yourself a hepatitis B carrier; professional evaluation is necessary. 35:38 Through blood tests and ultrasound... Accurate Detection of Liver Fibrosis 36:55 Stopping Medication Without a Consultation Despite Normal Liver Index May Lead to Fatal Liver Failure 38:34 Strictly Meeting the Three Requirements for Testing: Medication Can Be Considered for Discontinuation After Two Years 39:09 Intensive Follow-up is Necessary After Discontinuing Medication to Prevent Viral Relapse 39:47 Addressing the Root Cause and Eliminating the Virus: Source Treatment Reverses Cirrhosis 40:06 End-Stage Liver Disease with Ascites and Jaundice: Once Like a Death Sentence 40:53 Medical Systemic Therapy Offers Hope for Mid-to-Late Stage Liver Cancer 41:24 Early-Stage Liver Cancer May Be Curable Through Surgical Electrocautery 42:01 Targeted Immunotherapy: A Two-Pronged Approach to Fight Liver Cancer 43:33 Through Cocktail Therapy, 30% of Patients Can Successfully Shrink Tumors 44:45 Side Effects of Targeted Immunotherapy: Be Aware of Proteinuria and High Blood Pressure 46:02 Regular Health Checkups, Regular Exercise, and Abstaining from Alcohol